logo

LLY

Eli Lilly·NYSE
--
--(--)
--
--(--)
3.36 / 10
Netural

The stock displays challenging fundamental strength (3.4/10). Encouraging metrics: Days sales outstanding and Interest coverage ratio (EBIT / Interest expense) (%), although drawbacks are visible in PB-ROE and Revenue-MV. This profile warrants a prudent stance.

Fundamental(3.36)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.00
Score1/3
Weight9.28%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value44.70
Score2/3
Weight1.98%
1M Return1.11%
Days sales outstanding
Value60.79
Score2/3
Weight2.01%
1M Return1.10%
Profit-MV
Value-0.71
Score2/3
Weight18.45%
1M Return8.45%
Net income-Revenue
Value1.42
Score3/3
Weight21.94%
1M Return9.29%
PB-ROE
Value1.41
Score0/3
Weight5.51%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value41.08
Score2/3
Weight-1.85%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value44.70
Score2/3
Weight0.76%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight23.78%
1M Return10.15%
Cash-MV
Value0.14
Score2/3
Weight18.13%
1M Return8.41%
Is LLY fundamentally strong?
  • LLY scores 3.36/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 31.67% net margin, 48.47 P/E ratio, 41.94 P/B ratio, and 95.42% earnings growth, these metrics solidify its Netural investment rating.